Ear Infection (Middle Ear): Bulging TM Clues, Amoxicillin First-Line & Mastoid Escalation

A middle-ear infection, formally acute otitis media, is a suppurative inflammation of the air-filled cavity that lies medial to the tympanic membrane and houses the ossicles. The cleft normally drains and ventilates through the eustachian tube into the nasopharynx; when a viral upper respiratory infection or allergic inflammation swells that pathway, mucociliary clearance collapses, negative pressure draws in nasopharyngeal flora, and bacteria proliferate behind the drum. The resulting pus produces the bulging, opaque tympanic membrane that anchors the diagnosis, alongside conductive hearing loss as the ossicular chain is damped by fluid.

AOM sits at one end of an otitis-media continuum. Otitis media with effusion (OME) describes sterile middle-ear fluid without acute inflammation and is the more common late-stage finding after AOM resolves; chronic suppurative otitis media (CSOM) refers to persistent otorrhoea through a non-healing perforation. Mistaking effusion for active infection drives antibiotic overuse, while missing genuine AOM in a febrile infant risks complications—so the clinical pivot lives in pneumatic otoscopy and a careful history of acute symptom onset.

The peak incidence between 6 and 24 months reflects anatomy and immunology: a short, horizontal, more compliant eustachian tube, immature humoral immunity, and dense exposure to viral pathogens through siblings and daycare. Adults can develop AOM but typically present after barotrauma, sinus disease, or with underlying nasopharyngeal pathology; persistent unilateral effusion in an adult is a red flag for nasopharyngeal mass and warrants ENT review even if pain is mild.

Treatment thresholds depend less on whether AOM is present and more on severity grading and laterality. Major paediatric guidelines pair severity with age to decide between immediate antibiotics and a structured 48–72-hour observation window.

↔On a small screen, swipe or scroll sideways to see the full table.

Local guidance varies on observation eligibility for children under 2 years. Use age, severity, laterality, and follow-up reliability together rather than any single threshold in isolation.

The classic AOM picture is a child who has been snuffly with a viral cold for a few days, then suddenly becomes febrile, irritable, and tugs or rubs at the affected ear, with disturbed sleep and reduced feeding. Older children verbalise sharp ear pain and aural fullness; in pre-verbal toddlers the picture rests on indirect cues that nurses are often best placed to observe at triage.

Typical presentation

• Sudden-onset otalgia after a viral URI; pain often worse when supine.
• Fever—commonly 38–39 °C, occasionally higher; rigors suggest more severe disease.
• Aural fullness, conductive hearing impairment, balance disturbance.
• Irritability, broken sleep, reduced oral intake, ear pulling, refusing to lie on the affected side.
• Spontaneous purulent otorrhoea—often dramatically relieves pain because pressure has decompressed.

Atypical or under-recognised features

• Vague abdominal pain or vomiting in young children with no localising ear complaint.
• Behavioural change or apparent inattention from bilateral OME after AOM, mimicking neurodevelopmental concerns.
• Adult presentations with referred jaw or pharyngeal pain—exclude dental and temporomandibular sources before pinning on the ear.
• Recurrent unilateral AOM in an adult—think nasopharyngeal mass and arrange ENT assessment.

Why does AOM follow a cold?

Predominant bacterial pathogens

• Streptococcus pneumoniae—historically the dominant pathogen; conjugate vaccination has shifted serotype distribution.
• Non-typeable Haemophilus influenzae—often paired with purulent conjunctivitis (the “otitis–conjunctivitis syndrome”).
• Moraxella catarrhalis—almost universally beta-lactamase producing.
• Streptococcus pyogenes—associated with higher rates of perforation and mastoiditis.
• Staphylococcus aureus and Pseudomonas aeruginosa—mostly in CSOM or after tympanostomy tubes, not typical primary AOM.

Patient and environmental risk factors

• Age 6–24 months and male sex (modest effect).
• Daycare attendance, large household size, exposure to siblings with URIs.
• Tobacco-smoke exposure and indoor air pollution.
• Bottle feeding, particularly supine; absence of breastfeeding in the first months.
• Pacifier use beyond infancy in some cohorts.
• Anatomic and syndromic factors: cleft palate, Down syndrome, craniofacial anomalies, ciliary dyskinesia.
• Atopy and untreated allergic rhinitis.
• Family history of recurrent AOM; immunoglobulin deficiencies in atypical recurrence.

Modifiable vs fixed

• Modifiable: smoke exposure, bottle position, pacifier weaning, vaccination uptake, allergic-rhinitis control.
• Fixed or slow-moving: craniofacial anatomy, immunological background, age and daycare exposure during infancy.

AOM is a clinical diagnosis. Imaging and laboratory tests rarely add value in uncomplicated disease; the work is in the otoscopy and the history.

Clinical assessment

• History: rapidity of onset, prior URI, fever pattern, prior episodes, recent antibiotics in the last 30 days, immunisation status, daycare exposure, allergies.
• General examination: hydration, level of distress, neurological status, postauricular and pinna inspection.
• Pneumatic otoscopy: assess colour, contour (bulging, neutral, retracted), translucency, mobility on insufflation, presence of perforation or otorrhoea.
• Tuning-fork or whisper test in older children and adults to gauge conductive impairment when feasible.

Distinguishing AOM from OME

↔On a small screen, swipe or scroll sideways to see the full table.

Adjuncts

• Tympanometry: objective measure of middle-ear compliance—useful when otoscopy is equivocal or to confirm persistent effusion.
• Audiometry: indicated for persistent effusion >3 months, suspected hearing impact, or recurrent disease before considering tubes.
• Tympanocentesis or aspirate culture: reserved for treatment failure, immunocompromise, neonates, or complicated infection—typically performed by ENT.
• Imaging: CT temporal bones if mastoiditis is suspected; MRI when intracranial complication is on the table. Routine bloods add little to uncomplicated AOM.

Key bedside thresholds

↔On a small screen, swipe or scroll sideways to see the full table.

Once AOM is confirmed on otoscopy, the next decisions sit in three layers: severity, age and laterality, and whether to start antibiotics now or arrange structured observation. The flow below mirrors how ward and clinic teams typically reason.

1. Confirm AOM: Bulging drum on pneumatic otoscopy, fresh otorrhoea through perforation, or marked tympanic membrane changes with acute illness. Without these, treat as OME or alternative diagnosis.
2. Grade severity: Severe = moderate–severe otalgia, otalgia ≥48 h, or fever ≥39 °C. Severe AOM at any age → immediate antibiotics.
3. Age and laterality (non-severe):
   • <6 months → immediate antibiotics.
   • 6–23 months bilateral → immediate antibiotics.
   • 6–23 months unilateral → antibiotics or shared-decision observation if reliable follow-up.
   • ≥24 months → observation often appropriate with safety-net.
4. Set the safety-net: If observing, document explicit return precautions, ensure analgesia, and arrange review at 48–72 hours; provide a back-up prescription where local pathways allow.
5. Reassess at 48–72 hours: No improvement → start antibiotics (if observed) or change to amoxicillin–clavulanate (if amoxicillin started). Worsening → review for complications.
6. Escalate to ENT or paediatrics for: failure of second-line therapy, persistent otorrhoea >1–2 weeks despite treatment, mastoid signs, neurological features, vertigo, sensorineural loss, or suspected nasopharyngeal pathology in adults.

“Sore ear plus fever” hides several mimics; the otoscopic picture and surrounding examination usually separate them more reliably than the symptom history alone.

↔On a small screen, swipe or scroll sideways to see the full table.

Therapy targets pain first—often within minutes of the consultation—and only then layers in antimicrobial decisions. Match the agent to age, severity, allergy history, prior antibiotics, and pathogen prevalence; do not extend duration beyond what local guidelines recommend.

Analgesia for every patient

• Weight-based paracetamol scheduled around the clock for the first 24–48 hours.
• Ibuprofen as an alternative or adjunct in age-appropriate, well-hydrated children.
• Topical analgesic ear drops (where licensed) for older children with intact drums and severe pain.
• Avoid systemic decongestants and antihistamines—they have not shown benefit and risk adverse effects in young children.

First-line antibiotics

• High-dose amoxicillin (~80–90 mg/kg/day in two divided doses)—first choice in most uncomplicated AOM with no recent antibiotic exposure or concurrent conjunctivitis.
• Amoxicillin–clavulanate—first choice when amoxicillin was used in the last 30 days, when “otitis–conjunctivitis syndrome” suggests H. influenzae, in recurrent AOM, or after first-line failure at 48–72 hours.
• Standard course: 10 days for children <2 years and severe disease; 5–7 days may be acceptable in older children with non-severe disease per local pathways.

Penicillin allergy and treatment failure

• Non-anaphylactic mild reaction: oral cefdinir, cefuroxime, or cefpodoxime aligned to local formulary.
• Anaphylactic or severe reaction: azithromycin or clarithromycin (lower pneumococcal coverage) or clindamycin where pneumococcal susceptibility supports it.
• Severe illness, vomiting, or oral therapy failure: single-dose intramuscular ceftriaxone (often repeated for up to three doses) or admission for IV therapy.
• Re-examine if no improvement at 48–72 hours; broaden to amoxicillin–clavulanate, switch class for documented allergy, or reconsider diagnosis.

Surgical and procedural options

• Tympanostomy tubes (grommets): for recurrent AOM (≥3 in 6 months / ≥4 in 12 months) or persistent OME >3 months with hearing or developmental concern.
• Adenoidectomy: often considered alongside repeat tubes or in older children, particularly with nasal obstruction.
• Myringotomy without tubes: reserved for selected severe pain or complication management by ENT.

Special populations

• Infants <6 months: always treat with antibiotics; consider admission and broader work-up if systemically unwell.
• Children with cleft palate, Down syndrome, immunodeficiency, cochlear implants: lower threshold for ENT input and earlier surgical consideration.
• Pregnancy: amoxicillin remains preferred; use age- and pregnancy-compatible analgesia.
• Adults with diabetes, immunocompromise, or skull-base concern: early ENT review and lower threshold for imaging if pain, swelling, or cranial-nerve signs persist.

• Pain first, antibiotics second: ensure adequate analgesia is given before discharge or onto the ward; document weight-based dosing intervals.
• Verify the diagnosis is otoscopy-based: at handover, distinguish AOM (bulging drum or otorrhoea) from OME or “?ear infection”; do not start antibiotics for the latter.
• Specimen and culture timing: reserve aspirate culture for treatment failure, neonates, immunocompromise, or atypical pathogens; do not delay antibiotics in severe illness while awaiting samples.
• Drug safety: screen for penicillin allergy reaction type, recent antibiotic use, and renal or hepatic impairment; counsel on diarrhoea risk and on completing the prescribed course.
• Follow-up cadence: in-person or telephone review at 48–72 hours for observed cases or if symptoms persist; routine recheck at 2–4 weeks for any AOM with otorrhoea or in younger children.
• Hearing monitoring: document baseline language milestones and arrange audiology for persistent bilateral effusion or recurrent disease.
• MDT triggers: ENT for surgical candidates, audiology for hearing concerns, paediatrics for systemic illness, microbiology for resistant or unusual pathogens, speech and language therapy for delayed milestones.
• Documentation: ear examined, drum description, severity score, prescribing decision, safety-net advice given, follow-up owner, parental teach-back recorded.

Short-term

• Tympanic membrane perforation with otorrhoea—usually self-resolving over weeks.
• Acute mastoiditis with postauricular swelling and protruding pinna.
• Facial-nerve palsy from intratemporal extension.
• Acute labyrinthitis with vertigo and sensorineural hearing loss.
• Bezold’s abscess and other deep neck-space infections (rare).
• Intracranial extension: meningitis, sigmoid-sinus thrombosis, brain abscess (rare but devastating).

Long-term

• Persistent OME with conductive hearing loss and possible speech or learning impact in young children.
• Chronic suppurative otitis media with permanent perforation and recurrent otorrhoea.
• Cholesteatoma—keratinising squamous epithelium within the middle ear, often heralded by foul-smelling otorrhoea and progressive hearing loss.
• Tympanosclerosis from repeated inflammation and tube placements.
• Recurrent disease driving repeated antibiotic exposure and selection pressure.

Preventive levers split into vaccination, behavioural modification, and treatment of upstream risk. Pneumococcal conjugate and influenza vaccines reduce AOM incidence and resistant pneumococcal disease; reinforcing uptake at well-child visits is one of the highest-yield clinic activities. Reducing tobacco-smoke exposure, encouraging breastfeeding for the first 6 months, avoiding supine bottle feeding, and trialling pacifier weaning beyond infancy are pragmatic risk reductions. Treating allergic rhinitis, addressing adenoid hypertrophy, and considering tympanostomy tubes in recurrent disease prevent further episodes. Routine antibiotic prophylaxis is no longer recommended because of resistance concerns; xylitol products and probiotics show inconsistent benefit and are not standard of care.

Most uncomplicated AOM episodes resolve within 1–2 weeks; pain typically eases within 24–48 hours of analgesia and any indicated antibiotic. Around 60–70% of children still have residual middle-ear effusion at 2 weeks, falling to roughly 10–25% at 3 months; hearing usually recovers as fluid clears. Long-term sequelae are uncommon when AOM is recognised and treated appropriately, but recurrent disease, persistent effusion, or established CSOM can produce conductive hearing loss with measurable speech and developmental impact in young children, justifying timely audiology and ENT input rather than open-ended watchful waiting.

Triage cues nurses notice first

The under-twos rarely point to their ears reliably. Listen instead for a triad of recent cough or coryza, new fever, and disrupted sleep with ear-rubbing. Children who refuse to lie flat for vital-sign checks and only settle upright on a parent are advertising middle-ear pressure pain.

Bedside monitoring checklist

• Temperature, heart rate, respiratory rate, oxygen saturation, and capillary refill at presentation and per local paediatric early warning score.
• Structured pain assessment appropriate to age (FLACC, Wong-Baker, numeric).
• Hydration: oral intake, urine output, mucous membranes, fontanelle in infants.
• Ear examination findings (drum colour, contour, mobility, otorrhoea) recorded objectively.
• Neurological observations if any concern about meningismus, drowsiness, or focal weakness.
• Postauricular skin inspection at every shift in inpatients with prolonged courses.

Communication and health literacy

Translate the watchful-waiting plan into a concrete script: explain that most ear infections settle without antibiotics if pain is treated, set the timeline (review at 48–72 hours if not improving), and give an explicit list of red flags—high fever, swelling behind the ear, new floppiness or confusion, sudden balance problems, facial weakness. For non-English-speaking families, use a trained interpreter rather than a child sibling, and confirm understanding with teach-back.

Recurrent disease and family fatigue

Families of recurrent-AOM children often arrive exhausted and seeking antibiotics. Acknowledge the burden, document the episode count, and route them toward audiology and ENT referral pathways rather than another reflex prescription. Hearing impact at this age can drive school and behaviour concerns long before parents articulate it.

Adult workflow

For adults presenting with recurrent unilateral middle-ear disease, persistent unilateral effusion, or new pulsatile tinnitus, examine the pharynx, palpate cervical nodes, and arrange ENT review—nasopharyngeal pathology is a meaningful differential and easy to miss in a busy primary-care list.

While organising transfer or waiting for senior review, ensure analgesia and antipyretics are given per protocol, secure venous access if systemically unwell, repeat early-warning scores on schedule, and document a precise neurological baseline so the receiving team can detect change.

These NCLEX-style clinical judgment practice items focus on the nursing priorities for this condition — recognise cues, escalate red flags, take safe action and evaluate outcomes (NCSBN Clinical Judgment Measurement Model) — through Priority FIRST, SATA, deterioration trends, multi-patient triage, ordered response, matrix matching and a compact cloze on the topic of acute otitis media (AOM) recognition, antibiotic stewardship and the mastoiditis / intracranial / facial-palsy / paediatric red flags.